← Back to headlines
Teva and NeuroGen Partner on Migraine Drug in Chinese Mainland
Pharmaceutical companies Teva and NeuroGen have announced a partnership to develop and distribute a migraine drug in the Chinese mainland market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
